4.7 Article

Treatment Decisions for Patients with cancer during the cOVID-19 Pandemic

Journal

CANCER DISCOVERY
Volume 11, Issue 6, Pages 1330-1335

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-21-0210

Keywords

-

Categories

Funding

  1. ESMO-CoCare
  2. CCC19

Ask authors/readers for more resources

Cancer patients have been significantly impacted by the COVID-19 pandemic, leading to changes in treatment decisions and disruptions in care. It is crucial for oncologists to make appropriate therapeutic choices based on clear recommendations to prevent a surge in cancer-related deaths in the coming months.
Patients with cancer have been disproportionally affected by the COVID-19 pandemic, with high rates of severe outcomes and death. Similarly, treatment decisions in this vulnerable population have been altered to a major degree during the past year, with significant disruption of care reported. Although complex, therapeutic choices in patients with cancer in times of COVID-19 are critical, as they may save thousands of lives. A mounting body of evidence, in addition to clear recommendations by multiple international societies, can help oncologists decide appropriately the necessity to administer antineoplastic regimens, helping to avoid a surge in cancer-related deaths in the upcoming months.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available